Several experimental and epidemiological studies in CKD have illustrated correlations between high FGF23 levels and various deleterious effects, including left ventricular hypertrophy [4], vascular calcification [5], impaired immune system, anemia, and decreased bone mineralization [6]. This evidence concerns the gene FGF23 and left ventricular hypertrophy.